Androgen Deprivation Therapy: Along the Prostate Cancer Continuum

New Orleans, LA US
May 16, 2015

This educational activity will present significant and compelling data on androgen deprivation therapy (ADT) in prostate cancer. Presentations will focus on agents affecting androgen levels in the serum and in tumor cells, particularly the different administration mechanisms and impact on patient outcome. Participants will be challenged to consider the risks and benefits of ADT in various clinical situations, and how to make evidence-based clinical decisions, in order to identify the most appropriate care and patient management. NCCN Guidelines identification of best practices and future directions of clinical issues will be considered.

Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit(s)™
  • 1.50 Attendance
Course opens: 
Course expires: 
Event starts: 
05/16/2015 - 5:30pm
Event ends: 
05/16/2015 - 8:00pm
Morial Convention Center
900 Convention Center Blvd.
Room 255-257
New Orleans, LA 70130
United States

Available Credit

  • 1.50 AMA PRA Category 1 Credit(s)™
  • 1.50 Attendance


Please login or register to take this course.